Potential Use of Sofosbuvir in the Prophylaxis for Rabies

1 Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY, United States, 2 Departments of Pathology and Obstetrics and Gynecology and Women’s Health, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States, 3 Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, United States

[1]  P. German,et al.  The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection , 2018, Drug Metabolism and Disposition.

[2]  B. Canard,et al.  Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2′‐modified nucleotide analogues , 2017, Antiviral research.

[3]  M. Sofia.  Enter Sofosbuvir: The Path to Curing HCV , 2016, Cell.

[4]  P. Gong,et al.  Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation , 2016, Proceedings of the National Academy of Sciences.

[5]  S. Hill,et al.  Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis , 2016, PLoS medicine.

[6]  A. Nishizono,et al.  Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis , 2015, The Journal of infectious diseases.

[7]  F. Zeiler,et al.  Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned , 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  Helen Yu,et al.  Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus , 2015, Antimicrobial Agents and Chemotherapy.

[9]  Antonio Lazcano,et al.  Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic Implications , 2015, PloS one.

[10]  Bo Liang,et al.  Structure of the L Protein of Vesicular Stomatitis Virus from Electron Cryomicroscopy , 2015, Cell.

[11]  H. Wilde,et al.  The "Milwaukee protocol" for treatment of human rabies is no longer valid. , 2015, The Pediatric infectious disease journal.

[12]  Louise Taylor,et al.  Correction: Estimating the Global Burden of Endemic Canine Rabies , 2015, PLoS neglected tropical diseases.

[13]  A. Mathias,et al.  Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir , 2015, Clinical Pharmacokinetics.

[14]  Xiaorong Yang,et al.  Targeting structural dynamics of the RNA-dependent RNA polymerase for anti-viral strategies. , 2014, Current opinion in virology.

[15]  A. T. Velthuis.  Common and unique features of viral RNA-dependent polymerases , 2014, Cellular and Molecular Life Sciences.

[16]  S. Whelan,et al.  Sensitivity of the Polymerase of Vesicular Stomatitis Virus to 2′ Substitutions in the Template and Nucleotide Triphosphate during Initiation and Elongation* , 2014, The Journal of Biological Chemistry.

[17]  G. Keating,et al.  Sofosbuvir: First Global Approval , 2014, Drugs.

[18]  N. Ford,et al.  Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  E. Kopel,et al.  Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient , 2012, Emerging infectious diseases.

[20]  C. Hatz,et al.  Rabies: relevance, prevention, and management in travel medicine. , 2012, Infectious disease clinics of North America.

[21]  C. V. van Dolleweerd,et al.  Passive immunity in the prevention of rabies. , 2012, The Lancet. Infectious diseases.

[22]  R. Ruigrok,et al.  Structural insights into the rhabdovirus transcription/replication complex. , 2011, Virus research.

[23]  P. Walker,et al.  Overview, Prevention, and Treatment of Rabies , 2009, Pharmacotherapy.

[24]  H. Wilde,et al.  Survival after treatment of rabies. , 2005, The New England journal of medicine.

[25]  C. Rupprecht,et al.  Survival after treatment of rabies with induction of coma. , 2005, The New England journal of medicine.

[26]  C. Rupprecht,et al.  Prophylaxis against rabies , 2004 .

[27]  Katherine J. Johnson,et al.  The global availability of rabies immune globulin and rabies vaccine in clinics providing direct care to travelers. , 2013, Journal of travel medicine.

[28]  WHO Expert Consultation on Rabies. Second report. , 2013, World Health Organization technical report series.